Fed Watch: December Rate Hike Likely Based on Fed Official's Language

Posted on by Matt Thalman

Matt Thalman - INO.com Contributor - ETFs


Over the past few weeks, the likelihood of a December rate hike by the Federal Reserve Bank has grown substantially. Both economic data and hints from a number of Federal Reserve policymakers now point towards a December rate hike and now on Wall Street 70% of investors polled believe a rate hike in December is possible. So let us take a look at the data and what Fed officials are saying that is making investors believe a hike is coming.

Data

One of the most compelling data points is the October jobs number. Expected to come in at 185,000, but blew that figure out of the water when actually coming in at 271,000. The unemployment rate fell to 5%, from 5.1% and average hourly earnings rose 0.4% for the month. Furthermore, the increase in pay on a year-over-year basis was 2.5%, the highest increase the jobs market has seen since July 2009. Continue reading "Fed Watch: December Rate Hike Likely Based on Fed Official's Language" →

Two Stocks That Deserve Your Attention Today

Posted on by The INO.com Team

When I was combing through the recent Trade Triangles scan this morning, two stocks jumped out at me. These two stocks have been in disfavor with investors and were generally cast aside by the general public.

The first stock I will be looking at today is Yelp, Inc. (NYSE:YELP). This stock traded over the $100 level back in the first quarter of 2014. Since that time the stock has generally eroded and recently traded down to the $20 area. This morning, Yelp triggered a buy signal with a green monthly Trade Triangle at $27.70. This signal represents the first monthly signal since 10/13/2014 when a red monthly Trade Triangle was triggered at $64.70. I have an upside target for Yelp of $40, which represents a 61.8% Fibonacci retracement. Continue reading "Two Stocks That Deserve Your Attention Today" →

This Shooting Star Shows No Sign Of Slowing Down

Posted on by Daniel Cross

Daniel Cross - INO.com Contributor - Equities


Value investors love finding a small cap stock that's outperforming while flying under the radar. Wall Street analysts tend to focus on larger companies which means their smaller counterparts can often be mispriced – a scenario that value hunters live for.

Finding an undervalued stock in an industry that's growing fast as well is like having your cake and eating it too.

The US hosts the largest medical supplies market in the world valued at around $110 billion and expected to reach $133 billion by next year. The US constituted 38% of the worldwide medical equipment market (as of 2012) and exports are expected to rise over the next several years even in the face of a challenging environment driven by the high relative value of the dollar. Continue reading "This Shooting Star Shows No Sign Of Slowing Down" →

Did Yesterday's Rally Cause A Reversal In The Market?

Posted on by The INO.com Team

While the rally yesterday was dramatic and to the upside, I don't believe that it was enough to reverse the decline set by the previous weeks drop. Yesterday, The Trade Triangle's indicated that a move to the sidelines was in order and a neutral stance should be adopted. I feel that is the optimum position to have at the moment.

Many of the indices are now back to an area that should provide some resistance to yesterday's rally. One of the things I will be watching closely this week is how the markets close on Friday. Especially with next being be a short and abbreviated trading week because of Thanksgiving.

Overall, 2015 was not a good year for hedge funds. I made that statement before, but several major hedge funds have dramatically reduced their exposure to stocks, I think this is a smart move as I still feel as though this market is undecided as to which direction it wants to go. Continue reading "Did Yesterday's Rally Cause A Reversal In The Market?" →

This Healthcare Juggernaut Continues To Deliver

Posted on by Noah Kiedrowski

Noah Kiedrowski - INO.com Contributor - Biotech


Introduction

I posited that CVS presented a compelling investment opportunity in the healthcare space. This premise was rooted in the fact that CVS has been highly acquisitive, robust growth rate, growing its dividends over time and has an aggressive share buyback program in place. CVS recently reported robust earnings and continued to drive and position itself for long-term success. With its recent acquisitions and partnerships, specifically the acquisition Target’s pharmacies and Omnicare will significantly expand its footprint and ability to dispense prescriptions to the general public and in assisted living and long-term care facilities that serve the senior patient population. As the United States continues to absorb an ageing population alongside growing overall healthcare costs, more specifically prescription drug costs, CVS looks poised to benefit and continue to outperform the broader market. The most recent earnings report underscores this premise and CVS continues to deliver continued growth and positioning for long-term success.

2015 Q3 Earnings

Recently, CVS reported strong earnings for the quarter ending September 30th, 2015. Net revenue increased more than 10% to $36.8 billion while adjusted EPS increased to $1.28 or 11.5% as compared to the prior year quarter. Continue reading "This Healthcare Juggernaut Continues To Deliver" →